Bert ’t Hart

1.0k total citations
15 papers, 641 citations indexed

About

Bert ’t Hart is a scholar working on Immunology, Pathology and Forensic Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Bert ’t Hart has authored 15 papers receiving a total of 641 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 6 papers in Pathology and Forensic Medicine and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Bert ’t Hart's work include Immunotherapy and Immune Responses (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Multiple Sclerosis Research Studies (5 papers). Bert ’t Hart is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Multiple Sclerosis Research Studies (5 papers). Bert ’t Hart collaborates with scholars based in Netherlands, United Kingdom and France. Bert ’t Hart's co-authors include Michel Vierboom, Paul A. Smith, Sandra Amor, Margreet Jonker, Erwin L. A. Blezer, David Baker, Ronald E. Bontrop, Gianvito Martino, Gıancarlo Comı and Chiara Cossetti and has published in prestigious journals such as Annals of Neurology, European Journal of Immunology and Journal of Neuropathology & Experimental Neurology.

In The Last Decade

Bert ’t Hart

15 papers receiving 621 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bert ’t Hart Netherlands 11 254 222 168 144 115 15 641
Christine Ewing Australia 7 574 2.3× 158 0.7× 252 1.5× 66 0.5× 113 1.0× 8 883
Joachim Malotka Germany 13 423 1.7× 229 1.0× 280 1.7× 97 0.7× 67 0.6× 20 811
Ingrid Teige Sweden 14 556 2.2× 229 1.0× 102 0.6× 129 0.9× 78 0.7× 40 939
Linda Spatz United States 18 583 2.3× 145 0.7× 100 0.6× 398 2.8× 370 3.2× 31 935
Marvin M. van Luijn Netherlands 18 571 2.2× 223 1.0× 434 2.6× 39 0.3× 82 0.7× 43 1.1k
Yufen Qin United States 14 598 2.4× 152 0.7× 289 1.7× 116 0.8× 141 1.2× 24 911
Silke Häusser‐Kinzel Germany 15 343 1.4× 89 0.4× 409 2.4× 60 0.4× 61 0.5× 17 647
Ryan C. Winger United States 12 450 1.8× 279 1.3× 254 1.5× 31 0.2× 48 0.4× 25 946
Kim B. Nguyen Australia 12 393 1.5× 195 0.9× 159 0.9× 24 0.2× 41 0.4× 21 648
Susan A. Fordham Australia 11 891 3.5× 194 0.9× 271 1.6× 73 0.5× 165 1.4× 15 1.2k

Countries citing papers authored by Bert ’t Hart

Since Specialization
Citations

This map shows the geographic impact of Bert ’t Hart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bert ’t Hart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bert ’t Hart more than expected).

Fields of papers citing papers by Bert ’t Hart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bert ’t Hart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bert ’t Hart. The network helps show where Bert ’t Hart may publish in the future.

Co-authorship network of co-authors of Bert ’t Hart

This figure shows the co-authorship network connecting the top 25 collaborators of Bert ’t Hart. A scholar is included among the top collaborators of Bert ’t Hart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bert ’t Hart. Bert ’t Hart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Vanhove, Bernard, Nicolas Poirier, Fádi Fakhouri, et al.. (2017). Antagonist Anti-CD28 Therapeutics for the Treatment of Autoimmune Disorders. Antibodies. 6(4). 19–19. 10 indexed citations
2.
Roy, Maarten Van, Cedric Ververken, Els Beirnaert, et al.. (2015). The preclinical pharmacology of the high affinity anti-IL-6R Nanobody® ALX-0061 supports its clinical development in rheumatoid arthritis. Arthritis Research & Therapy. 17(1). 135–135. 145 indexed citations
3.
Snir, Omri, Erik Lönnblom, Hüseyin Uysal, et al.. (2014). Type II collagen antibody response is enriched in the synovial fluid of rheumatoid joints and directed to the same major epitopes as in collagen induced arthritis in primates and mice. Arthritis Research & Therapy. 16(4). R143–R143. 40 indexed citations
4.
Jonker, Margreet, Jacqueline Wubben, Krista G. Haanstra, Michel Vierboom, & Bert ’t Hart. (2012). Comparative analysis of inflammatory infiltrates in collagen-induced arthritis, kidney graft rejection and delayed-type hypersensitivity in non-human primates. Inflammation Research. 62(2). 181–194. 4 indexed citations
5.
Pluchino, Stefano, Angela Gritti, Erwin L. A. Blezer, et al.. (2009). Human neural stem cells ameliorate autoimmune encephalomyelitis in non‐human primates. Annals of Neurology. 66(3). 343–354. 147 indexed citations
6.
Jagessar, S. Anwar, Paul A. Smith, Erwin L. A. Blezer, et al.. (2008). Autoimmunity Against Myelin Oligodendrocyte Glycoprotein Is Dispensable for the Initiation Although Essential for the Progression of Chronic Encephalomyelitis in Common Marmosets. Journal of Neuropathology & Experimental Neurology. 67(4). 326–340. 40 indexed citations
7.
Vierboom, Michel, Cecilia Johnsson, Bert ’t Hart, & Margreet Jonker. (2006). Monotherapy with the vitamin D3 analogue MC1288 does not result in prolonged kidney allograft survival in rhesus monkeys. Transplant International. 19(5). 396–403. 5 indexed citations
8.
Bessis, Natacha, Delphine Lemeiter, L. Laroche, et al.. (2006). Engraftment of cutaneous fibroblasts within synovial membrane in a nonhuman primate: Short-term results. Joint Bone Spine. 74(1). 48–51. 8 indexed citations
9.
Amor, Sandra, Paul A. Smith, Bert ’t Hart, & David Baker. (2005). Biozzi mice: Of mice and human neurological diseases. Journal of Neuroimmunology. 165(1-2). 1–10. 53 indexed citations
10.
Smith, Paul A., M. Morris-Downes, Nicole Heijmans, et al.. (2005). Epitope spread is not critical for the relapse and progression of MOG 8-21 induced EAE in Biozzi ABH mice. Journal of Neuroimmunology. 164(1-2). 76–84. 24 indexed citations
11.
Vierboom, Michel, Margreet Jonker, Ronald E. Bontrop, & Bert ’t Hart. (2005). Modeling human arthritic diseases in nonhuman primates.. Arthritis Research & Therapy. 7(4). 145–145. 50 indexed citations
12.
Smith, Paul A., Nicole Heijmans, Esther C.W. Breij, et al.. (2005). Native myelin oligodendrocyte glycoprotein promotes severe chronic neurological disease and demyelination in Biozzi ABH mice. European Journal of Immunology. 35(4). 1311–1319. 50 indexed citations
13.
Heijmans, Nicole, Paul A. Smith, M. Morris-Downes, et al.. (2005). Encephalitogenic and tolerogenic potential of altered peptide ligands of MOG and PLP in Biozzi ABH mice. Journal of Neuroimmunology. 167(1-2). 23–33. 6 indexed citations
14.
Poliani, Pietro Luigi, Herbert Brok, Roberto Furlan, et al.. (2001). Delivery to the Central Nervous System of a Nonreplicative Herpes Simplex Type 1 Vector Engineered with the Interleukin 4 Gene Protects Rhesus Monkeys from Hyperacute Autoimmune Encephalomyelitis. Human Gene Therapy. 12(8). 905–920. 46 indexed citations
15.
Jonker, Margreet, et al.. (1991). Autoimmunity in non-human primates: the role of major histocompatibility complex and T cells, and implications for therapy. Human Immunology. 32(1). 31–40. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026